Published in J Anesth on May 25, 2011
Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells. J Transl Med (2014) 0.88
Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery? J Anesth (2013) 0.87
Are we causing the recurrence-impact of perioperative period on long-term cancer prognosis: Review of current evidence and practice. J Anaesthesiol Clin Pharmacol (2014) 0.83
Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression. Braz J Med Biol Res (2017) 0.75
Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol (2016) 0.75
Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression. Mol Med Rep (2015) 0.75
Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients. Clin Transl Med (2017) 0.75
Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2-mediated Wnt/β-catenin pathway. Exp Ther Med (2017) 0.75
The Effects of Perioperative Anesthesia and Analgesia on Immune Function in Patients Undergoing Breast Cancer Resection: A Prospective Randomized Study. Int J Med Sci (2017) 0.75
Osmotin Protects H9c2 Cells from Simulated Ischemia-Reperfusion Injury through AdipoR1/PI3K/AKT Signaling Pathway. Front Physiol (2017) 0.75
Cancer metastasis: building a framework. Cell (2006) 19.67
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet (2010) 13.13
Arachidonic acid metabolism. Annu Rev Biochem (1986) 6.56
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 6.17
The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis (2009) 5.01
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res (2007) 4.69
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res (1998) 3.79
Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst (2010) 2.80
Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem (1993) 2.61
Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci (2002) 2.51
Immunodepression after major surgery in normal patients. Surgery (1975) 2.48
Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. J Clin Oncol (2010) 2.32
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res (2005) 2.32
Fatty fish consumption and risk of prostate cancer. Lancet (2001) 2.27
Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells. J Leukoc Biol (2010) 2.22
Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition (2002) 2.19
The metabolic response to stress: an overview and update. Anesthesiology (1990) 2.18
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci (2008) 2.12
Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol (1998) 2.11
Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol (2002) 1.88
Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg (2000) 1.59
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Cancer (2003) 1.55
In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol (1998) 1.52
Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol (2009) 1.49
Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol (2008) 1.44
Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg (2003) 1.40
Fish consumption and breast cancer risk: an ecological study. Nutr Cancer (1989) 1.38
PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Blood (2007) 1.38
Suppression of cellular immunity by surgical stress. Surgery (2000) 1.36
Natural killer cells and cancer. Cancer (1996) 1.33
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res (2008) 1.31
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol (2010) 1.26
Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation. J Biol Chem (2004) 1.26
Increased surgical stress promotes tumor metastasis. Surgery (2003) 1.16
Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett (2002) 1.11
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res (2004) 1.10
Cyclooxygenase-2 in oncogenesis. Clin Chim Acta (2010) 1.08
Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. Eur J Anaesthesiol (2010) 1.07
Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol (2001) 1.07
GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells. Biomed Pharmacother (2010) 1.00
Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells. Breast Cancer Res (2005) 0.97
The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells. Oncogene (2010) 0.95
Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol (2007) 0.94
The prognostic significance of natural killer cytotoxicity in patients with colorectal cancer. Arch Surg (1987) 0.94
Induction and mechanism of apoptotic cell death by propofol in HL-60 cells. Acta Anaesthesiol Scand (2002) 0.93
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia. J Mol Med (Berl) (2009) 0.92
The influence of anaesthetic technique upon the immune response to hysterectomy. A comparison of propofol infusion and isoflurane. Anaesthesia (1995) 0.89
A pathway through interferon-gamma is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells. Eur J Biochem (2003) 0.89
Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia (2010) 0.89
Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth (2009) 0.89
Effect of propofol and isoflurane anaesthesia on the immune response to surgery. Anaesthesia (2004) 0.88
Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines. Mol Cell Biochem (2010) 0.87
COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67. Cancer Epidemiol (2010) 0.86
Promotion of interferon-gamma production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E₂ production using intravenous anesthetic propofol. Int Immunopharmacol (2010) 0.80
Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells. Can J Anaesth (2009) 0.80
[Clinical study on total intravenous anesthesia with droperidol, fentanyl and ketamine--7. Effects on natural killer cell activity]. Masui (1991) 0.79
Propofol suppresses prostaglandin E(2) production in human peripheral monocytes. Immunopharmacol Immunotoxicol (2009) 0.78
Vaccines using dendritic cells, differentiated with propofol, enhance antitumor immunity in mice. Immunopharmacol Immunotoxicol (2009) 0.75
Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines. Int Immunopharmacol (2005) 0.75
Awake tracheal intubation through the laryngeal mask in neonates with upper airway obstruction. Paediatr Anaesth (2008) 2.68
Truview video laryngoscope in patients with difficult airways. Anesth Analg (2006) 1.44
LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid Redox Signal (2008) 1.29
Airway management in an infant with double aortic arch. J Anesth (2010) 1.10
[Gas leakage from an anesthetic circuit caused by mis-installation of a canister]. Masui (2008) 1.05
An unusual case of airway obstruction at the tip of an endotracheal tube caused by insertion of a nasogastric tube. J Anesth (2008) 1.04
Propofol and midazolam inhibit gastric emptying and gastrointestinal transit in mice. Anesth Analg (2004) 1.00
Isoflurane induces second window of preconditioning through upregulation of inducible nitric oxide synthase in rat heart. Am J Physiol Heart Circ Physiol (2005) 0.98
Emergency airway management of an extremely low-birth-weight infant with subglottic stenosis. Paediatr Anaesth (2008) 0.97
Another reason to choose the left molar approach of laryngoscopy: to spare the incisor teeth. Anesthesiology (2002) 0.95
[A case of the transversus abdominis plane block in a super obese patient using a convex probe]. Masui (2013) 0.95
Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol (2007) 0.94
Regulation of Vav localization in membrane rafts by adaptor molecules Grb2 and BLNK. Immunity (2003) 0.92
Airway management of a patient with tracheal stenosis for surgery in the prone position. Can J Anaesth (2004) 0.87
The Pentax-AWS video-laryngoscope: the first experience in one hundred patients. Anesth Analg (2008) 0.86
Successful management of cesarean section in a patient with Romano-Ward syndrome using landiolol, a selective and short-acting beta1 receptor antagonist. J Anesth (2005) 0.86
The intravenous anesthetic propofol inhibits hypoxia-inducible factor 1 activity in an oxygen tension-dependent manner. FEBS Lett (2004) 0.85
Edaravone, a free radical scavenger, mitigates both gray and white matter damages after global cerebral ischemia in rats. Brain Res (2009) 0.85
Pentobarbital inhibits ketamine-induced dopamine release in the rat nucleus accumbens: a microdialysis study. Anesth Analg (2003) 0.85
Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients. Anesth Analg (2010) 0.84
The inhibition of the N-methyl-D-aspartate receptor channel by local anesthetics in mouse CA1 pyramidal neurons. Anesth Analg (2002) 0.84
The inhibitory effect of sodium nitroprusside on HIF-1 activation is not dependent on nitric oxide-soluble guanylyl cyclase pathway. Biochem Biophys Res Commun (2004) 0.83
Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1. Retrovirology (2009) 0.83
[Use of the laryngeal mask airway prevents gas leak around a tracheal tube]. Masui (2009) 0.82
Pneumothorax after pneumonectomy: surgery with successful double lobe ventilation. Jpn J Thorac Cardiovasc Surg (2006) 0.81
[Anesthesia for cesarean section in a patient with cor triatriatum]. Masui (2005) 0.81
Role of mitochondrial KATP channels and protein kinase C in ischaemic preconditioning. Clin Exp Pharmacol Physiol (2003) 0.81
A case of suspected severe pulmonary embolism in a living-related liver transplantation donor. J Clin Anesth (2005) 0.81
Promotion of interferon-gamma production by natural killer cells via suppression of murine peritoneal macrophage prostaglandin E₂ production using intravenous anesthetic propofol. Int Immunopharmacol (2010) 0.80
Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells. Can J Anaesth (2009) 0.80
[Fentanyl shows different effects by administration routes on bispectral index during spinal anesthesia in patients undergoing cesarean section]. Masui (2006) 0.80
The effects of local anesthetics on cellular hypoxia-induced gene responses mediated by hypoxia-inducible factor 1. J Anesth (2005) 0.80
[Use of a gum elastic bougie for tracheal intubation with Pentax-AWS airway scope]. Masui (2008) 0.80
The differential effects of nitrous oxide and xenon on extracellular dopamine levels in the rat nucleus accumbens: a microdialysis study. Anesth Analg (2006) 0.80
[Appropriate dose of isobaric bupivacaine with fentanyl in spinal anesthesia for cesarean section]. Masui (2005) 0.79
An antagonistic effect of esmolol on beta-3 adrenoceptor in brown adipose tissue in rats. J Anesth (2002) 0.79
Anticonvulsant effects of sevoflurane on amygdaloid kindling and bicuculline-induced seizures in cats: comparison with isoflurane and halothane. J Anesth (2002) 0.79
Ketamine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices is mediated not only via NMDA receptors but also via sigma receptors. Brain Res (2002) 0.79
[Pentax AWS airway scope]. Masui (2007) 0.78
[TruViewEVO2 videolaryngoscope]. Masui (2007) 0.78
Propofol suppresses prostaglandin E(2) production in human peripheral monocytes. Immunopharmacol Immunotoxicol (2009) 0.78
Suppression of phagosome proteolysis and Matrigel migration with the α2-adrenergic receptor agonist dexmedetomidine in murine dendritic cells. Immunopharmacol Immunotoxicol (2013) 0.77
Intravenous anesthetic propofol suppresses prostaglandin E2 production in murine dendritic cells. J Immunotoxicol (2011) 0.77
Time-related cuff pressures of the laryngeal tube with and without the use of nitrous oxide. Anesth Analg (2004) 0.77
Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease. Brain Res (2011) 0.77
Effect of subhypnotic doses of dexmedetomidine on antitumor immunity in mice. Immunopharmacol Immunotoxicol (2005) 0.77
[Insertion of a laryngeal mask airway before removal of a nasotracheal tube in a patient after anterior spine surgery]. Masui (2006) 0.76
Intravenous anesthetic propofol suppresses prostaglandin E2 and cysteinyl leukotriene production and reduces edema formation in arachidonic acid-induced ear inflammation. J Immunotoxicol (2014) 0.76
Intravenous anesthetic propofol suppresses leukotriene production in murine dendritic cells. J Immunotoxicol (2012) 0.76
Adenosine and a nitric oxide donor enhances cardioprotection by preconditioning with isoflurane through mitochondrial adenosine triphosphate-sensitive K+ channel-dependent and -independent mechanisms. Anesthesiology (2004) 0.76
[NMDA receptor antagonist neurotoxicity and psychotomimetic activity]. Masui (2003) 0.76
Ketamine attenuates hypocapnia-induced neuronal damage in the caudoputamen in a rat model of chronic cerebral hypoperfusion. Neurosci Lett (2004) 0.75
Vaccines using dendritic cells, differentiated with propofol, enhance antitumor immunity in mice. Immunopharmacol Immunotoxicol (2009) 0.75
Integrated pharmacological preconditioning in combination with adenosine, a mitochondrial KATP channel opener and a nitric oxide donor. J Thorac Cardiovasc Surg (2003) 0.75
Endothelium, nitric oxide, and anesthetics. J Anesth (2003) 0.75
[Anesthetic management of pneumonorrhaphy for one-lung patient]. Masui (2006) 0.75
[Propofol triggers a marked body temperature increase in a patient with fulminant malignant hyperthermia (MH) without inducing other symptoms of MH]. Masui (2010) 0.75
[Anesthesia for a severe ankylosing spondylitis patient whose posture had been restricted to only sitting for over 20 years]. Masui (2002) 0.75
[Laryngeal mask during emergence from anesthesia in intubated patients with asthmatic attack or ischemic heart disease]. Masui (2005) 0.75
Opioid receptor stimulation does not affect cellular hypoxia-induced gene responses mediated by hypoxia-inducible factor 1 in cultured cell lines. J Anesth (2005) 0.75
[Anesthetic management of an 18-trisomy neonate with high frequency ventilation]. Masui (2005) 0.75
A patient with cardiac amyloidosis successfully managed with propofol anesthesia. J Anesth (2002) 0.75
[Bronchial blocking with a balloon wedge pressure Catheter in a small infant]. Masui (2006) 0.75
Difficult pulmonary artery catheterization caused by an interluminal leak. J Anesth (2002) 0.75
[Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients]. Masui (2014) 0.75
[Spinal anesthesia in a patient with SMON disease]. Masui (2010) 0.75
[Anesthetic Management for a Patient with Stiff-person Syndrome]. Masui (2016) 0.75
[Comparison of analgesic effects of intravenous flurbprofen and suppository indomethacin after laparoscopic cholecystectomy]. Masui (2003) 0.75
[Undetachable connection between a reinforced endotracheal tube and L connector]. Masui (2005) 0.75
Impact of steroid medication before hospital admission on barotrauma in mechanically ventilated patients with acute respiratory distress syndrome in intensive care units. J Anesth (2014) 0.75
A new method using flow cytometry to measure the effects of drugs on gastric emptying and gastrointestinal transit in mice. Arzneimittelforschung (2004) 0.75
[Case of successful management with mirtazapine for prolonged pain after esophagectomy]. Masui (2012) 0.75
[Brain protection with mild hypothermia during carotid artery clamping]. Masui (2005) 0.75
The Laryngeal Mask Airway for exchange of a nasal for an orotracheal tube in a patient with Treacher Collins syndrome. J Clin Anesth (2007) 0.75
More difficulty in removing an arrow epidural catheter. Anesth Analg (2006) 0.75
[Airway obstruction during one-lung ventilation using a bronchial blocker and a tracheostomy tube]. Masui (2004) 0.75
[Lethal air embolism after spray of tissue adhesive-fibrinogen and factor XIII aerosol during laparoscopic partial nephrectomy]. Masui (2007) 0.75
[Anesthesia for laparoscopic cryptorchidpexy in a patient with congenital myopathy]. Masui (2003) 0.75
[Propofol anesthesia for fetal sedation]. Masui (2004) 0.75
[Use of the Pentax-AWS videolaryngoscope and an exchange catheter for tube exchange]. Masui (2008) 0.75
[Fiberoptic tracheal intubation aided by jaw lifting in a patient with an epiglottic cyst]. Masui (2002) 0.75
[Difficult tracheal intubation in a patient suspected of malignant hyperthermia]. Masui (2003) 0.75
[Use of sugammadex in a patient with narrow angle glaucoma]. Masui (2011) 0.75
[A case of Rh incompatible transfusion after use of anti-D immunoglobulin for unexpected intraoperative massive hemorrhage]. Masui (2013) 0.75
[Combined use of the airway scope and fiberoptic bronchoscopy for tracheal intubation in a patient with a large epiglottic cyst]. Masui (2009) 0.75
[Use of the Pentax-AWS videolaryngoscope for bougie-assisted exchange of tracheal tubes]. Masui (2009) 0.75
[Anesthetic management of therapeutic angiogenesis with autologous bone marrow cells for medically intractable angina pectoris]. Masui (2003) 0.75